Healio: How do treatment goals differ for younger vs. older patients with type 2 diabetes? Buse: The most important aspect of tailoring treatment for younger vs. older patients is understanding ...

LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient ...

C-peptide's dual role involves protective mechanisms against DR and potential harmful effects in type 2 diabetes. Monitoring FCP levels is crucial for managing DR risk in patients with type 2 diabetes ...

The findings provide crucial insights into the potential for diabetes medications to influence long-term brain health. Dr Catriona Reddin, senior author, researcher at the University of Galway and ...

There’s still a lot we don’t know about how effective acupuncture is for treating diabetes symptoms. But some of the newest research seems to confirm that it’s at least safe and somewhat ...

Researchers have observed in a new study that stress hyperglycemia (SHR) ratio could be a useful predictor of neovascular glaucoma (NVG) in patients with ...

Beta-blockers can treat a variety of conditions including diabetes. They might cause certain side effects such as headaches and fatigue. People with diabetes tend to develop heart disease or ...

Researchers have established in a new study that triglyceride-glucose (TyG) levels have a U-shaped correlation with the development of diabetes in patients with non-alcoholic fatty liver disease ...

Among the employees who have been dismissed are chaplains for grieving families, a counselor for abuse victims, and a specialist in helping patients quit smoking When Mass General Brigham ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn. Nearly 40% of patients diagnosed with type 2 ...

More than 90% of people with diabetes have type 2 diabetes, but most of the diabetes technology on the market is for type 1 patients. That’s something diabetes device developers are hoping to change ...